tert-Butyl (2-bromo-4-fluorobenzyl)(isopropyl)carbamate

Catalog No.: 
ACHVXS812
CAS No.: 
2358751-04-7
Molecular Formula: 
C15H21BrFNO2
Molecular Weight: 
346.24
tert-Butyl (2-bromo-4-fluorobenzyl)(isopropyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$355.00InquiryInquiry
1g98%$1077.00InquiryInquiry
5g98%$2155.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (2-bromo-4-fluorobenzyl)(isopropyl)carbamate
IUPAC Nametert-butyl (2-bromo-4-fluorobenzyl)(isopropyl)carbamate
MDL No.MFCD31924898
Molecular FormulaC15H21BrFNO2
Molecular Weight346.24
SMILESO=C(OC(C)(C)C)N(CC1=CC=C(F)C=C1Br)C(C)C
InChI KeyBUXSJELWWLVTMO-UHFFFAOYSA-N
Synonymtert-Butyl 2-bromo-4-fluorobenzyl(isopropyl)carbamate;Carbamic acid, N-[(2-bromo-4-fluorophenyl)methyl]-N-(1-methylethyl)-, 1,1-dimethylethyl ester
CAS No.2358751-04-7

Synthetic Route by SureRoute

1. ACHVXS812 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSCBE043 route compound structure diagram
    ACSCBE0431293323-82-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHVXS812 route product structure diagram
    ACHVXS8122358751-04-7
Inquiry

2. ACHVXS812 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWCVT965 route compound structure diagram
    ACWCVT96551170-55-9In Stock
  2. Plus
  3. ACDHLW908 route compound structure diagram
    ACDHLW90861150-57-0In Stock
  4. Then
  5. ACHVXS812 route product structure diagram
    ACHVXS8122358751-04-7
Inquiry

3. ACHVXS812 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHVXS812 route product structure diagram
    ACHVXS8122358751-04-7
Inquiry

Comments (0)